Echo and ECG Findings in Neuropediatrics

NCT ID: NCT07184008

Last Updated: 2025-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-01

Study Completion Date

2026-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluate the echo-electrocardiographic findings in patients with neurological affection to identify potential cardiac involvement, and explore correlation between cardiac and neurological abnormalities.Objectives are To assess echocardiographic findings in patients with neurological affection , to analyze ECG patterns in the same patient group and to explore clinical significance of detected cardiac findings in the management of neurological patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Neurological disorders in pediatric patients represent a significant cause of morbidity and mortality worldwide. These disorders may have multifactorial etiologies , including congenital , infectious , metabolic , inflammatory , and vascular causes , with clinical presentations ranging from seizures to motor deficits and altered consciousness.

The interplay between neurological conditions and cardiovascular involvement has gained increasing attention in recent years. Cardiac manifestations may occur secondary to neurological diseases due to autonomic dysregulation , systemic inflammation , or direct neuro cardiac interaction , potentially affecting patient outcomes.

Several studies have demonstrated that pediatric patients with neurological diseases, such as epilepsy, cerebral palsy, and acute encephalitis, may exhibit significant echocardiographic and electrocardiographic changes. These changes may be transient or persistent, and recognizing them early is crucial for comprehensive patient management.

Moreover, neurological complications may also arise as a consequence of primary cardiac disease. Conditions such as congenital heart disease, infective endocarditis, or shunt lesions can predispose to embolic stroke, brain abscess, or hypoxic-ischemic injury, representing critical intersections between heart and brain.

Electrocardiographic abnormalities are frequently observed in children with congenital and acquired heart disease, and some of these changes are associated with neurological complications. For instance, prolonged QT interval or QT dispersion has been linked to an increased risk of arrhythmia-related cerebral hypoperfusion and syncope, which in turn can precipitate transient ischemic attacks or seizures.

Atrial fibrillation, although less common in children, may also occur in certain congenital heart conditions and cardiomyopathies. It is a well-recognized source of cardioembolic stroke, as thrombi formed in the atria can dislodge and travel to the cerebral circulation. Early detection of such arrhythmias by ECG is essential to prevent neurological sequelae.

Understanding the cardiac profile of patients with neurological affection may therefore help in early detection, appropriate intervention, and reduction of long-term complications.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Migraine Seizures Encephalopathy Arrythmia Congenital Heart Disease Cardiomyopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. pediatric patients (1 month - 18 years) diagnosed with a neurological disorder (e.g., stroke, epilepsy, demyelinating disorders, neuromuscular diseases and migraine) confirmed by clinical data (history \& examination) and/or neuroimaging ( CT \& MRI ).
2. Both sexes (Male \& Female) were included in the study.
3. Patients willing to participate and provide informed consent

Exclusion Criteria

1. patients younger than 1 month old.
2. critically unstable patients in whom echocardiography could not be performed safely or was technically in adequate for interpretation.
3. patients refuse to participate in the research.
Minimum Eligible Age

1 Month

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Andrew Youssef Qestandy Youssef

Assiut University

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Andrew Youssef Qestandy

Role: CONTACT

+201152156076

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Ecg & Echo in neuropediatrics

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Risk Factors in Tachycardiomyopathy
NCT03418467 ACTIVE_NOT_RECRUITING